Several studies [85–87] have shown that targeted inhibition of the TXNIP/NLRP3 signaling pathway may also improve the pathological manifestations of osteoarthritis and promote the repair of cartilage damage in OA cell models and mouse models. This evidence concerns the gene NLRP3 and osteoarthritis.